StockNews.com assumed coverage on shares of Veradigm (NASDAQ:MDRX – Free Report) in a report released on Sunday. The firm issued a hold rating on the software maker’s stock.
Veradigm Price Performance
Shares of MDRX stock opened at $10.66 on Friday. The business’s 50-day moving average price is $9.62 and its 200-day moving average price is $9.34. Veradigm has a 12 month low of $5.01 and a 12 month high of $12.86.
Institutional Trading of Veradigm
An institutional investor recently bought a new position in Veradigm stock. Innealta Capital LLC purchased a new stake in Veradigm Inc. (NASDAQ:MDRX – Free Report) in the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor purchased 3,974 shares of the software maker’s stock, valued at approximately $38,000.
Veradigm Company Profile
Veradigm Inc, a healthcare technology company, provides information technology solutions and services to healthcare organizations in the United States, Canada, and internationally. It offers electronic health records (EHR), information connectivity, private cloud hosting, outsourcing, analytics, patient access, and population health management solutions.
Recommended Stories
- Five stocks we like better than Veradigm
- What Are Dividends? Buy the Best Dividend Stocks
- Warren Buffett, Cathie Wood Own Nu Holdings, Should You?
- How to buy stock: A step-by-step guide for beginners
- MercadoLibre Down 23% After Missed Earnings: Time to Buy the Dip?
- What is a Dividend Harvesting Strategy and How Can Investors Profit from it?
- ORIC: Working with Two Pharma Giants, Analysts See +100% Upside
Receive News & Ratings for Veradigm Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Veradigm and related companies with MarketBeat.com's FREE daily email newsletter.
